Physician profile
Jared Blau
NPI 1437504271
$2,923.10
in general payments reported to CMS, 2019-2025
11 companies · $556 in 2025
The $556 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $63.47 · 2023: $953 · 2024: $1,350 · 2025: $556.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,126 · Travel and Lodging: $734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,126.00 |
| Travel and Lodging | $733.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $550.22 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Motiva USA, LLC | $502.99 | 2024-2025 | |
| Medical Device Business Services, INC. | $426.84 | 2024 | |
| Merz North America, INC. | $386.76 | 2022-2023 | Xeomin |
| Abbvie INC. | $365.44 | 2023-2024 | |
| Tela Bio, INC. | $163.34 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Dilon Technologies, INC. | $131.86 | 2023 | Hemoblast Bellows |
| Arcutis Biotherapeutics, INC. | $128.87 | 2024 | Zoryve |
| Rti Surgical, INC | $125.94 | 2023 | |
| Smith+Nephew, INC. | $80.72 | 2023 | Grafix Pl |
| Solventum Corporation | $60.12 | 2025 | V.A.C. Veraflo Cleanse Choice, V.A.C.Instill, V.A.C.Ulta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Blau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.